BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou W, Tan W, Huang X, Yu HG. Doxorubicin combined with Notch1-targeting siRNA for the treatment of gastric cancer. Oncol Lett 2018;16:2805-12. [PMID: 30127866 DOI: 10.3892/ol.2018.9039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Neves AR, Albuquerque T, Faria R, Gonçalves AM, Santos C, Vivès E, Boisguérin P, Passarinha LA, Sousa Â, Costa D. Development of WRAP5 Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma Therapy. Pharmaceutics 2022;14:2213. [DOI: 10.3390/pharmaceutics14102213] [Reference Citation Analysis]
2 Sritharan S, Guha S, Hazarika S, Sivalingam N. Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance. Apoptosis 2022. [PMID: 35716277 DOI: 10.1007/s10495-022-01742-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nechaeva A, Artyukhov A, Luss A, Shtilman M, Gritskova I, Shulgin A, Motyakin M, Levina I, Krivoborodov E, Toropygin I, Chistyakov E, Gurevich L, Mezhuev Y. Synthesis of Amphiphilic Copolymers of N-Vinyl-2-pyrrolidone and Allyl Glycidyl Ether for Co-Delivery of Doxorubicin and Paclitaxel. Polymers 2022;14:1727. [DOI: 10.3390/polym14091727] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Ashrafizadeh M, Zarrabi A, Hushmandi K, Hashemi F, Rahmani Moghadam E, Raei M, Kalantari M, Tavakol S, Mohammadinejad R, Najafi M, Tay FR, Makvandi P. Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy. ACS Comb Sci 2020;22:669-700. [PMID: 33095554 DOI: 10.1021/acscombsci.0c00099] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 13.0] [Reference Citation Analysis]
5 Tyagi A, Sharma AK, Damodaran C. A Review on Notch Signaling and Colorectal Cancer. Cells 2020;9:E1549. [PMID: 32630477 DOI: 10.3390/cells9061549] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
6 Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L, Liu J, Xu Y, Shen Y, Yang M. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020;19:62. [PMID: 32192494 DOI: 10.1186/s12943-020-01185-7] [Cited by in Crossref: 140] [Cited by in F6Publishing: 159] [Article Influence: 46.7] [Reference Citation Analysis]
7 Farah E, Li C, Cheng L, Kong Y, Lanman NA, Pascuzzi P, Lorenz GR, Zhang Y, Ahmad N, Li L, Ratliff T, Liu X. NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells. J Biol Chem 2019;294:8543-54. [PMID: 30940724 DOI: 10.1074/jbc.RA118.006983] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]